Kiniksa Pharmaceuticals International, plc KNSA Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
Based on trailing twelve months.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's earnings yield?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported earnings yield of 2% in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's earnings yield changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's earnings yield increased by 288.7% year-over-year, from -1.1% to 2%.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's earnings yield?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's earnings yield has grown at a -32.3% compound annual growth rate (CAGR), from -13.3% to 1.9%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.